News | FFR Technologies | July 26, 2018

Updated SCAI Expert Consensus Says Either FFR, iFR Can Be Used

iFR reference numbers posted for new users in the cath lab at Northwestern Medicine's Central DuPage Hospital in Winfield, Ill.

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus statement in July for the use of invasive coronary physiological assessments. It recommends either fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) technologies can be used to assess the hemodynamic significance of coronary lesions to determine if a stent is needed. The statement said physiologicaly guided percutaneous coronary intervention (PCI) results in better clinical outcomes and saves resources compared to angiographic image guidance alone.[1] 

Both iFR and FFR are deemed “definitely beneficial” for assessing the functional significance of intermediate coronary stenoses when noninvasive stress imaging is not available or does not provide a definitive answer. SCAI sees probable benefits when FFR or iFR are used to reclassify the number of vessels that are diseased in patients with multivessel disease.

SCAI’s updated consensus statement was published in the SCAI journal Catherization and Cardiovascular Interventions. Based on the data from the DEFINE-FLAIR and iFR Swedeheart trials showing that the technique is noninferior to FFR for guiding decisions about intervening on intermediate lesions in patients with stable angina or non-STEMI acute coronary syndrome (ACS).[2,3]

The authors also spend some time covering the utility of iFR and/or FFR in stable ischemic heart disease, multivessel coronary artery disease (CAD), left main coronary stenosis, ACS, STEMI, aortic stenosis, tandem and serial lesions, and bypass grafts.

Access the expert consensus statement article. 

 

Related FFR and iFR Content:

What is New in FFR Technology

VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation

ORBITA: FFR and iFR as Predictors Placebo-controlled Response to PCI

VIDEO: iFR Found More Cost Effective Over Standard FFR

 

References: 

1. Amir Lotfi, Justin E. Davies, William F. Fearon, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions, First published: 03 July 2018 https://doi.org/10.1002/ccd.27672

2. Justin E. Davies, Sayan Sen, Hakim-Moulay Dehbi, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI, N Engl J Med 2017; 376:1824-1834. DOI: 10.1056/NEJMoa1700445

3. Matthias Götberg, Evald H. Christiansen, Ingibjörg J. Gudmundsdottir, et al.  Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med 2017; 376:1813-1823. DOI: 10.1056/NEJMoa1616540
 

Related Content

Among high-risk, chronic, coronary patients who undergo angioplasty, there were no additional benefits from ticagrelor compared to the current standard of care clopidogrel. #AHA #AHA20 #AHA2020
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to clop
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major